comparemela.com
Home
Live Updates
Semaglutide Boosts Kidney Outcomes With Obesity and Cardiovascular Disease : comparemela.com
Semaglutide Boosts Kidney Outcomes With Obesity and Cardiovascular Disease
At prespecified 104-week time point, semaglutide was associated with lesser decline in eGFR than placebo.
Related Keywords
Stockholm ,
Sweden ,
Edinburgh ,
City Of ,
United Kingdom ,
Helenm Colhoun ,
,
Novo Nordisk ,
University Of Edinburgh ,
European Renal Association Congress ,
Healthday News ,
comparemela.com © 2020. All Rights Reserved.